Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: A pilot study

Pediatric Critical Care Medicine

Volumn 13, Issue 5, 2012, Pages 542-548

  Lechner, Evelyn ^a   Hofer, Anna ^b   Leitner Peneder, Gabriele ^a   Freynschlag, Roland ^b   Mair, Rudolf ^b   Weinzettel, Robert ^a   Rehak, Peter ^c   Gombotz, Hans ^b  

^a Children's and Maternity Hospital   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

children; levosimendan; low cardiac output syndrome; milrinone; open heart surgery

Indexed keywords

LACTIC ACID; LEVOSIMENDAN; MILRINONE;

ARTERIAL PRESSURE; ARTICLE; BODY SURFACE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTINUOUS INFUSION; DOUBLE BLIND PROCEDURE; FEMALE; FLUID RESUSCITATION; FORWARD HEART FAILURE; HEART INDEX; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; HUMAN; HYPOTENSION; INFANT; INTENTION TO TREAT ANALYSIS; MALE; OPEN HEART SURGERY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; WEANING;

ANALYSIS OF VARIANCE; BODY SURFACE AREA; CARDIAC OUTPUT; CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYDRAZONES; INFANT; INFANT, NEWBORN; INTENTION TO TREAT ANALYSIS; MALE; MILRINONE; PILOT PROJECTS; PREMEDICATION; PYRIDAZINES; STATISTICS, NONPARAMETRIC;

EID: 84866382568     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182455571     Document Type: Article

References (24)

1. Parr GV, Blackstone EH, Kirklin JW: Cardiac performance and mortality early after intra-cardiac surgery in infants and young children. Circulation 1975; 51:867-874
2. Wernovsky G, Wypij D, Jonas RA, et al: Postoperative course and hemodynamic profle after the arterial switch operation in neonates and infants. A comparison of low-fow cardio-pulmonary bypass and circulatory arrest. Circulation 1995; 92:2226-2235
3. Hoffman TM, Wernovsky G, Atz AM, et al: Eff-cacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107:996-1002
4. Vogt W, Läer S: Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe. Intensive Care Med 2011; 37:1390-1391
5. Vogt W, Läer S: Prevention for pediatric low-cardiac output syndrome: Resultsfrom the European survey EuLoCOS-Paed. Paediatr Anaesth 2011; 22:182-183
6. Stocker CF, Shekerdemian LS, Nørgaard MA, et al: Mechanisms of a reduced cardiac output and the effects of milrinone and levosimen-dan in a model of infant cardiopulmonary bypass. Crit Care Med 2007; 35:252-259
7. Sorsa T, Pollesello P, Rosevear PR, et al: Stere-oselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization. Eur J Pharmacol 2004; 486:1-8
8. Michaels AD, McKeown B, Kostal M, et al: Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation 2005; 111:1504-1509
9. Kivikko M, Lehtonen L, Colucci WS: Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003; 107:81-86
10. Slawsky MT, Colucci WS, Gottlieb SS, et al: Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102:2222-2227
11. Follath F, Cleland JG, Just H, et al: Steering Committee and Investigators of the Levosi-mendan Infusion versus Dobutamine (LIDO) Study: Effcacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 2002; 360:196-202
12. Nijhawan N, Nicolosi AC, Montgomery MW, et al: Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 1999; 34:219-228
13. Eriksson HI, Jalonen JR, Heikkinen LO, et al: Levosimendan facilitates weaning from car-diopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg 2009; 87:448-454
14. Turanlahti M, Boldt T, Palkama T, et al: Phar-macokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med 2004; 5:457-462
15. Egan JR, Clarke AJ, Williams S, et al: Levo-simendan for low cardiac output: A pediat-ric experience. J Intensive Care Med 2006; 21:183-187
16. Braun J P, Schneider M, Kastrup M, et al: Treatment of acute heart failure in an infant after cardiac surgery using levosi-mendan. Eur J Cardiothorac Surg 2004; 26: 228-230
17. Braun JP, Schneider M, Dohmen P, et al: Successful treatment of dilative cardio-myopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support. J Cardiothorac Vasc Anesth 2004; 18:772-774
18. Lechner E, Moosbauer W, Pinter M, et al: Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatr Crit Care Med 2007; 8:61-63
19. Luther YC, Schulze-Neick I, Stiller B, et al: [Levosimendan-long-term inodilation in an infant with myocardial infarction]. Z Kardiol 2004; 93:234-239
20. Namachivayam P, Crossland DS, Butt WW, et al: Early experience with Levosimendan in children with ventricular dysfunction. Pedi-atr Crit Care Med 2006; 7:445-448
21. Osthaus WA, Boethig D, Winterhalter M, et al: First experiences with intraoperative Levosi-mendan in pediatric cardiac surgery. Eur J Pediatr 2009; 168:735-740
22. Momeni M, Rubay J, Matta A, et al: Levo-simendan in congenital cardiac surgery: A randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth 2011; 25: 419-424
23. Booker PD: Myocardial stunning in the neo-nate. Br J Anaesth 1998; 80:371-383
24. Tibby SM, Hatherill M, Murdoch IA: Use of transesophageal Doppler ultrasonography in ventilated pediatric patients: Derivation of cardiac output. Crit Care Med 2000; 28:2045-2050